Skip to content

GE HealthCare Technologies GEHC Free cash flow yield

Free cash flow yield at other companies

Danaher logo
DanaherDHR
3.9%+0.6pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
Stryker logo
StrykerSYK
3.6%+1.1pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Agilent Technologies logo
Agilent TechnologiesA
3.3%-0.6pp
Cardinal Health logo
Cardinal HealthCAH
8.8%+1.5pp

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$27.82B-12.0%
P/E14.6×+0.1×
P/S1.3×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Calculated from GE HealthCare Technologies’s reported figures.

Based on trailing twelve months.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's free cash flow yield?
GE HealthCare Technologies (GEHC) reported free cash flow yield of 4.7% in Q1 2026.
What does free cash flow yield mean?
The spendable cash the business throws off each year as a percentage of its market price.
How do you interpret free cash flow yield?
Higher yield can mean better value — you pay less for each dollar of cash generated. A useful sanity check against earnings-based multiples, which non-cash items can distort.
How does free cash flow yield compare across companies?
Comparable across cash-generative companies; less meaningful for firms in heavy-investment phases with temporarily negative FCF.